Praktické lékárenství – 1/2020

www.praktickelekarenstvi.cz e20 AKTUÁLNÍ FARMAKOTERAPIE DUŠEVNÍ ONEMOCNĚNÍ V POPORODNÍM OBDOBÍ: SPECIFIKA A FARMAKOTERAPIE ČÁST II: PSYCHOTICKÉ PORUCHY A BIPOLÁRNÍ AFEKTIVNÍ PORUCHA PRAKTICKÉ LÉKÁRENSTVÍ 3. Spinelli MG. Postpartum psychosis: detection of risk and management. Am J Psychiat- ry. 2009 Apr;166(4): 405–408. 4. Sit D, Rothschild AJ, Wisner KL. A review of postpartum psychosis. J Womens Health (Larchmt). 2006; 15(4):352–68. 5. Holford N, Channon S, Heron J, Jones I. The impact of postpartum psychosis on part- ners. BMC Pregnancy Childbirth. 2018 Oct 23;18(1): 414. 6. Di Florio A, Smith S, Jones I. Postpartum psychosis. The Obstetrician & Gynaecologist 2013; 15: 145–150. 7. Jones I, Craddock N. Familiality of the puerperal trigger in bipolar disorder: results of a fa- mily study. Am J Psychiatry 2001; 158: 913–917. 8. Robertson E, Jones I, Haque S, Holder R, Craddock N. Risk of puerperal and non-puerperal recurrence of illness following bipolar affective puerperal (post-partum) psychosis. The Bri- tish Journal of Psychiatry. 2005; 186(3): 258–259. 9. Blackmore ER, Rubinow DR, O‘Connor TG, Liu X, Tang W, Craddock N, Jones I. Reprodu- ctive outcomes and risk of subsequent illness in women diagnosed with postpartum psy- chosis. Bipolar disorders. 2013; 15(4): 394–404. 10. Rajkumar, RP. Prolactin and psychopathology in schizophrenia: a literature review and reappraisal. Schozophrenia Res Treat. 2014; 12: 34. 11. Snellen M, Power J, Blankley G, Galbally M. Pharmacological lactation suppression with D2 receptor agonists and risk of postpartum psychosis: A systematic review. Aust N Z J Obstet Gynaecol. 2016 Aug; 56(4): 336–340. 12. Austin M-P, Highet N and the Expert Working Group. Mental Health Care in the Perina- tal Period: Australian Clinical Practice Guideline. 2017. 13. Howard LM, Goss C, Leese M, Appleby L, Thornicroft, G. The psychosocial outcome of pregnancy in women with psychotic disorders. Schizophr. Res., 2004, 71: 49–60. 14. Wakil L, Perea E, Penaskovic K, Stuebe A, Meltzer-Brody S. Exacerbation of psychotic di- sorder during pregnancy in the context of medication discontinuation. Psychosomatics. 2013; 54(3): 290–293. 15. Poinso, F., Gay, M. P., Glangeaud-Freudenthal, N. M. C., & Rufo, M. (2002). Care in a mother- -baby psychiatric unit: analysis of separation at discharge. Archives of women’s mental he- alth, 5(2), 49–58. 16. Salmon MP, Abel K, Webb R, Warburton AL, Appleby L. A national audit of joint mother and baby admissions to UK psychiatric hospitals: an overview of findings. Arch Womens Ment Health 2004; 7(1): 65–70. 17. Ramsauer B, Achtergarde S. Mothers with acute and chronic postpartum psycho- ses and impact on the mother-infant interaction. Schizophr Res. 2018 Feb 26. pii: S0920- 9964(18)30109-9. doi: 10.1016/j.schres.2018. 02. 032 18. Healy SJ, Lewin J, Butler S, Vaillancourt K, Seth-Smith F. Affect recognition and the qu- ality of mother-infant interaction: understanding parenting difficulties in mothers with schizophrenia. 19. Herbert HS, Manjula M, Philip M. Growing Up with a Parent having Schizophrenia: Ex- periences and Resilience in the Offsprings. Indian J Psychol Med. 2013; 35(2): 148–153. 20. Uguz F. Second-generation antipsychotics during the lactation period: A comparative systematic review on infant safety. J Clin Psychopharmacol. 2016; 36: 244–252. 21. Cuomo A, Goracci A, Fagiolini A. Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. J Affect Di- sord. 2018; 228:229-237. 22. Manouilenko I, Öhman I, Georgieva J. Long-acting olanzapine injection during preg- nancy and breastfeeding: a case report. Arch Womens Ment Health. 2018; 21: 587. 23. Merikangas KR, Jin R, He J-P, Kessler RC, Lee S, Sampson NA, et al. Prevalence and corre- lates of bipolar spectrum disorder in the World Mental Health Survey Initiative. Arch Gen Psychiatry. 2011; 68: 241. 24. Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007; 164: 1817–1824. 25. Viguera AC, Nonacs R, Cohen LS, Tondo L, Murray A, Baldessarini RJ. Risk of recurren- ce of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry. 2000; 157: 179–184. 26. Wesseloo R, Kamperman AM, Munk-Olsen T, Pop VJM, Kushner SA, Bergink V. Risk of po- stpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am J Psychiatry. 2016; 173: 117–127. 27. Maina G, Rosso G, Aguglia A, Bogetto F. Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian women. Arch Womens Ment Health. 2014; 17: 367–372. 28. Rohde A, Marneros A. Bipolar disorders during pregnancy, post partum and in me- nopause. In: Bipolar disord. Dordrecht: Kluwer Academic Publishers; 2000. p. 127–137. 29. Munk-Olsen T, Laursen TM, Meltzer-Brody S, Mortensen PB, Jones I. Psychiatric Disor- ders With Postpartum Onset: Possible Early Manifestations of Bipolar Affective Disorders. Arch Gen Psychiatry. 2012; 69(4): 428–434. 30. Kitzlerová E, Kališová L. Elektrokonvulzivní terapie v těhotenství (část 1): bezpečnost a účinnost. Čes a slov Psychiatr 2018; 114(2): 60–63. 31. Šebela A, Hanka J, Goetz M, Mohr P. Psychofarmaka během těhotenství – mírní, nebo zvyšují riziko pro plod? Část první: antidepresiva, antipsychotika. Psychiatr. praxi 2018; 19(1e): e12–e20.